Sunshine Biopharma, Inc.
SBFM
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.83M | -6.04M | -5.98M | -5.99M | -6.31M |
| Total Depreciation and Amortization | 349.70K | 344.10K | 332.00K | 298.80K | 267.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 793.60K | 1.76M | 1.76M | 1.62M | 1.06M |
| Change in Net Operating Assets | -644.40K | -1.75M | -1.43M | -3.02M | -2.75M |
| Cash from Operations | -5.33M | -5.69M | -5.31M | -7.10M | -7.73M |
| Capital Expenditure | -19.10K | -172.10K | -174.50K | -278.10K | -787.10K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 10.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -259.00K | -651.10K | -756.20K | -710.40K | -743.50K |
| Cash from Investing | -278.10K | -823.20K | -930.70K | -978.30K | -1.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 75.50K | 75.50K | 75.50K | 75.50K | 58.20K |
| Issuance of Common Stock | 8.53M | 4.39M | 4.75M | 5.64M | 7.54M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.60M | 4.47M | 4.82M | 5.72M | 7.60M |
| Foreign Exchange rate Adjustments | 450.80K | 832.30K | 855.80K | -538.10K | 462.50K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | 3.44M | -1.21M | -563.20K | -2.90M | -1.20M |